PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic finds early success with laser that destroys tumors with heat

2010-10-15
(Press-News.org) JACKSONVILLE, Fla. — Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated — meaning no visible tumors remained after the procedure.

They join their colleagues at Mayo Clinic's site in Rochester, Minn., who were the first to use laser ablation on patients with recurrent prostate tumors.

Although the treatment techniques are in the development stage, the physicians say the treatment is potentially beneficial against most tumors in the body — either primary or metastatic — as long as there are only a few in an organ and they are each less than 5 centimeters in size (about 2 inches in diameter). Patients also cannot have a pacemaker or certain metallic implants, since the procedure is done inside an MRI machine.

"Laser ablation offers us a way to precisely target and kill tumors without harming the rest of an organ. We believe there are a lot of potential uses of this technique — which is quite exciting," says Eric Walser, M.D., an interventional radiologist who has pioneered the technique at Mayo Clinic, Florida.

In the United States, laser ablation is primarily used to treat brain, spine and prostate tumors, but is cleared by the U.S. Food and Drug Administration (FDA) for any soft tissue tumor. Only a few centers have adapted the technique to tumors outside of the brain.

Dr. Walser has been using laser ablation since June. He learned the technique in Italy, where its use is more common, and he adapted it for patients at Mayo Clinic, Florida, many of whom are on a liver transplant waiting list. The clinic is a large liver transplant center, and a number of patients with cirrhosis have small tumors in their liver. "We treated the tumors to keep them at bay because we could not use chemotherapy in these patients, who are quite ill and are waiting for a new liver," he says. He also adapted it for use in treating kidney tumors.

The outpatient procedure is performed inside an MRI machine, which can precisely monitor temperature inside tumors. A special nonmetal needle is inserted directly into a tumor, and the laser is turned on to deliver light energy. Physicians can watch the temperature gradient as it rises, and they can see exactly in the organ where the heat is. When the tumor and a bit of tissue that surrounds it (which may harbor cancer cells) is heated to the point of destruction — which can be clearly seen on monitors — the laser is turned off. In larger tumors, several needles are inserted simultaneously.

Patients are given anesthesia because, during the 2.5-minute procedure they should not move, Dr. Walser says. Post-treatment side effects include some local pain and flulike symptoms as the body reacts to, and absorbs, the destroyed tissue, he says. These side effects usually subside in three days to one week.

Dr. Walser adds that laser ablation is a much more precise technology than similar methods that use probes, such as radiofrequency ablation, which also raises a tumor's temperature, and cryotherapy, which freezes tumors.

David Woodrum, M.D., Ph.D., from Mayo Clinic, Rochester, has also reported success using the new technique.

At the March meeting of the Society of Interventional Radiology, Dr. Woodrum, presented results from the first known cases of using MRI-guided laser ablation to treat prostate tumors. He said then that the safe completion of four clinical cases using the technique to treat prostate cancer in patients who had failed surgery "demonstrates this technology's potential."

Dr. Woodrum has now treated seven patients, including a patient with melanoma whose cancer had spread to his liver.

"MRI-guided ablation may prove to be a promising new treatment for prostate cancer recurrences," he says. "It tailors treatment modality (imaging) and duration to lesion size and location and provides a less invasive and minimally traumatic alternative for men."

Mayo is the country's leader in adapting the use of MRI-guided ablation for tumors outside of the brain, say the physicians, who have been collaborating on expanding use of the technology with Visualase Inc., of Houston. The company received FDA clearance in October 2009 for use of laser ablation. Neither Dr. Walser nor Dr. Woodrum has a financial arrangement with the company or a conflict of interest.

### About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers, and 50,100 allied health staff work at Mayo Clinic, which has campuses in Rochester, Minn; Jacksonville, Fla; and Scottsdale/Phoenix, Ariz.; and community-based providers in more than 70 locations in southern Minnesota., western Wisconsin and northeast Iowa. These locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education, visit www.mayo.edu. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories.

END



ELSE PRESS RELEASES FROM THIS DATE:

Perspectives on improving patient care: Genetics, personalized medicine, and behavioral intervention

2010-10-15
Personalized medicine — improving the fit between patient and treatment — has become a major focus of research in fields from cancer treatment to the psychopharmacology of mental disorders. Genetic studies have suggested that an individual's genetic makeup renders him either more or less sensitive to stressful social environments — but can an individual's unique genotype also determine the effectiveness of preventative or therapeutic behavioral interventions? The current issue of Perspectives on Psychological Science, a journal of the Association for Psychological Science, ...

Study: Waist circumference, not BMI, is best predictor of future cardiovascular risk in children

2010-10-15
Athens, Ga. – A new long-term study published by researchers at the University of Georgia, the Menzies Research Institute in Hobart, Australia and the Murdoch Childrens Research Institute in Melbourne, Australia suggests that waist circumference, rather than the commonly used body mass index measure, is the best clinical measure to predict a child's risk for cardiovascular disease and diabetes later in life. The researchers, whose results appear in the early online edition of the International Journal of Obesity, found that children with high waist circumference values ...

UT Dallas researcher helps reveal more complete picture of Martian atmosphere

2010-10-15
Instruments designed by a UT Dallas professor to measure atmospheric components on the surface of Mars have uncovered important clues about the planet's atmosphere and climate history. The findings, published in a recent issue of the journal Science, reveal how carbon dioxide isotopes have reacted to volcanic activity, water and weathering – thus forming a more complete picture of the current Martian atmosphere. The NASA mission in which this work was accomplished was the Phoenix Lander, an unmanned spacecraft deployed to Mars in 2008. UT Dallas Physics Professor ...

Anti-vomiting drug could prevent thousands of hospitalizations, save millions of dollars

2010-10-15
CHAPEL HILL – Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis. Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars ...

UCSB scientists discover inner workings of potent cancer drug

UCSB scientists discover inner workings of potent cancer drug
2010-10-15
(Santa Barbara, Calif.) –– A potent drug derived from an evergreen tree may soon save the lives of some patients with the deadliest form of breast cancer. According to the National Cancer Institute, breast cancer will claim approximately 40,000 lives in the U.S. this year. Scientists at UC Santa Barbara, in cooperation with scientists in the pharmaceutical industry, have discovered the mechanism by which this drug kills cancer cells. The team has isolated the drug's action in the test tube as well as in cancer cells. The results are reported in two studies published ...

Temperature rhythms keep body clocks in sync, UT Southwestern researchers find

2010-10-15
DALLAS – Oct. 14, 2010 – Researchers at UT Southwestern Medical Center have found that fluctuations in internal body temperature regulate the body's circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions. A light-sensitive portion of the brain called the suprachiasmatic nucleus (SCN) remains the body's "master clock" that coordinates the daily cycle, but it does so indirectly, according to a study published by UT Southwestern researchers in the Oct. 15 issue of Science. The SCN responds to light entering the eye, and so is sensitive ...

Researchers report advances vs. preeclampsia, including potential prediction

2010-10-15
PROVIDENCE, R.I. [Brown University] — In as many as 8 percent of pregnancies worldwide, women who seem fine for months develop preeclampsia, a serious complication causing symptoms including high blood pressure, severe swelling, and problems with placental development. The untreatable and unpredictable condition, with no known cause, often requires premature delivery, and can sometimes kill the mother and the fetus. In a new study, researchers led by a team at Brown University and Women & Infants Hospital describe two major advances: a well-defined animal model of preeclampsia ...

Researcher find fats galore in human plasma

Researcher find fats galore in human plasma
2010-10-15
Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood. "Everybody knows about blood lipids like cholesterol and triglycerides," said Edward A. Dennis, PhD, distinguished professor of pharmacology, chemistry and biochemistry at UC San Diego and ...

Need a study break to refresh? Maybe not, say Stanford researchers

2010-10-15
It could happen to students cramming for exams, people working long hours or just about anyone burning the candle at both ends: Something tells you to take a break. Watch some TV. Have a candy bar. Goof off, tune out for a bit and come back to the task at hand when you're feeling better. After all, you're physically exhausted. But a new study from Stanford psychologists suggests the urge to refresh (or just procrastinate) is – well – all in your head. In a paper published this week in Psychological Science, the researchers challenge a long-held theory that willpower ...

'Incoherent excitations' govern key phase of superconductor behavior: UBC research

2010-10-15
New research by University of British Columbia physicists indicates that high-temperature superconductivity in copper oxides is linked to what they term 'incoherent excitations'--a discovery that sheds light on the electronic response of these materials before they become superconducting. The study marks the first time researchers have been able to directly measure when electrons in a super conductor behave as independent well-defined particles, and when they evolve into ill-defined many-body entities. "We've never been able to directly quantify the nature of electron ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] Mayo Clinic finds early success with laser that destroys tumors with heat